Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090220

« Back to Dashboard

NDA 090220 describes ADENOSINE, which is a drug marketed by Akorn, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Hospira Inc, and Sagent Strides, and is included in eighteen NDAs. It is available from sixteen suppliers. Additional details are available on the ADENOSINE profile page.

The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the adenosine profile page.

Summary for 090220

Formulation / Manufacturing:see details

Pharmacology for NDA: 090220

Mechanism of ActionAdenosine Receptor Agonists

Medical Subject Heading (MeSH) Categories for 090220

Suppliers and Packaging for NDA: 090220

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADENOSINE adenosine INJECTABLE;INJECTION 090220 ANDA WOCKHARDT LIMITED 55648-630 55648-630-03 1 VIAL in 1 CARTON (55648-630-03) > 20 mL in 1 VIAL
ADENOSINE adenosine INJECTABLE;INJECTION 090220 ANDA WOCKHARDT LIMITED 55648-630 55648-630-04 1 VIAL in 1 CARTON (55648-630-04) > 30 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength3MG/ML
Approval Date:Jul 20, 2009TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: